American Century Companies Inc Myriad Genetics Inc Transaction History
American Century Companies Inc
- $167 Billion
- Q3 2024
A detailed history of American Century Companies Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, American Century Companies Inc holds 14,806 shares of MYGN stock, worth $219,572. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,806
Previous 50,805
70.86%
Holding current value
$219,572
Previous $1.24 Million
67.39%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding MYGN
# of Institutions
251Shares Held
90.7MCall Options Held
100KPut Options Held
34K-
Black Rock Inc. New York, NY15.2MShares$225 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$153 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.72MShares$99.6 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.18MShares$76.8 Million0.07% of portfolio
-
State Street Corp Boston, MA4.7MShares$69.8 Million0.01% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.2B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...